About: covid:afc99572834c677cd4f66c22e98eda2012f6f320

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:afc99572834c677cd4f66c22e98eda2012f6f320 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Hung, Chien-Fu Monie, Archana Huang, Bruce Wang, Mei-Cheng Wu, Chao-Yi Wu, T.-C Chih, Wen Tseng,
is schema:about of	named entity 'SPECIFIC' named entity 'BORTEZOMIB' named entity 'effects' named entity 'type 16' named entity 'develop' named entity 'immune responses' named entity 'calreticulin' named entity 'There' named entity 'DNA vaccination' named entity 'cell-mediated' named entity 'VACCINATED' named entity 'DATA' named entity 'THERAPIES' named entity 'TUMOR CELLS' named entity 'APPROACHES' named entity 'IMMUNITY' named entity 'ANTITUMOR' named entity 'FUTURE' named entity 'ANTIGEN' named entity 'CD8' named entity 'TUMOR' named entity 'MICE' named entity 'ENCODING' named entity 'RENDER' named entity 'DNA VACCINE' named entity 'CD8' named entity 'PROTEASOME INHIBITOR' named entity 'TC-1' named entity 'SPECIFIC' named entity 'INDUCED' named entity 'MEDIATED' named entity 'T CELL' named entity 'ANTIGEN' named entity 'ANTITUMOR' named entity 'URGENT' named entity 'COMPARED' named entity 'HUMAN PAPILLOMAVIRUS TYPE 16' named entity 'CLINICAL' named entity 'DNA' named entity 'HAVE' named entity 'EMPLOYMENT' named entity 'T CELL' named entity 'OUR' named entity 'IMMUNOTHERAPY' named entity 'CONTROL' named entity 'NEW' named entity 'TREATMENT' named entity 'PROTEASOME INHIBITOR' named entity 'CALRETICULIN' named entity 'STUDY' named entity 'TREATMENT' named entity 'BEARING' named entity 'CURRENT' named entity 'TRANSLATION' named entity 'THERAPEUTIC' named entity 'IMMUNE RESPONSES' named entity 'LED' named entity 'SUSCEPTIBLE' named entity 'CRT' named entity 'PROTEASOME INHIBITORS' named entity 'INCREASED APOPTOSIS' named entity 'GENERATED' named entity 'SIGNIFICANT' named entity 'TUMORS' named entity 'DNA VACCINATION' named entity 'GENERATE' named entity 'BORTEZOMIB' named entity 'MONOTHERAPY' named entity 'FOUND' named entity 'CANCER' named entity 'EFFECTS' named entity 'NEED' named entity 'THEIR' named entity 'COMBINATION' named entity 'LYSIS' named entity 'BETTER' covid:arg/afc99572834c677cd4f66c22e98eda2012f6f320 named entity 'immunotherapy' named entity 'study' named entity 'control' named entity 'vaccinated' named entity 'mice' named entity 'TC-1' named entity 'proteasome' named entity 'specific' named entity 'generate' named entity 'lysis' named entity 'HPV' named entity 'CRT' named entity 'CD8+' named entity 'antitumor' named entity 'antitumor'

Attributes

Values

Creator

Hung, Chien-Fu
Monie, Archana
Huang, Bruce
Wang, Mei-Cheng
Wu, Chao-Yi
Wu, T.-C
Chih, Wen
Tseng,

is schema:about of

named entity 'SPECIFIC'
named entity 'BORTEZOMIB'
named entity 'effects'
named entity 'type 16'
named entity 'develop'
named entity 'immune responses'
named entity 'calreticulin'
named entity 'There'
named entity 'DNA vaccination'
named entity 'cell-mediated'
named entity 'VACCINATED'
named entity 'DATA'
named entity 'THERAPIES'
named entity 'TUMOR CELLS'
named entity 'APPROACHES'
named entity 'IMMUNITY'
named entity 'ANTITUMOR'
named entity 'FUTURE'
named entity 'ANTIGEN'
named entity 'CD8'
named entity 'TUMOR'
named entity 'MICE'
named entity 'ENCODING'
named entity 'RENDER'
named entity 'DNA VACCINE'
named entity 'CD8'
named entity 'PROTEASOME INHIBITOR'
named entity 'TC-1'
named entity 'SPECIFIC'
named entity 'INDUCED'
named entity 'MEDIATED'
named entity 'T CELL'
named entity 'ANTIGEN'
named entity 'ANTITUMOR'
named entity 'URGENT'
named entity 'COMPARED'
named entity 'HUMAN PAPILLOMAVIRUS TYPE 16'
named entity 'CLINICAL'
named entity 'DNA'
named entity 'HAVE'
named entity 'EMPLOYMENT'
named entity 'T CELL'
named entity 'OUR'
named entity 'IMMUNOTHERAPY'
named entity 'CONTROL'
named entity 'NEW'
named entity 'TREATMENT'
named entity 'PROTEASOME INHIBITOR'
named entity 'CALRETICULIN'
named entity 'STUDY'
named entity 'TREATMENT'
named entity 'BEARING'
named entity 'CURRENT'
named entity 'TRANSLATION'
named entity 'THERAPEUTIC'
named entity 'IMMUNE RESPONSES'
named entity 'LED'
named entity 'SUSCEPTIBLE'
named entity 'CRT'
named entity 'PROTEASOME INHIBITORS'
named entity 'INCREASED APOPTOSIS'
named entity 'GENERATED'
named entity 'SIGNIFICANT'
named entity 'TUMORS'
named entity 'DNA VACCINATION'
named entity 'GENERATE'
named entity 'BORTEZOMIB'
named entity 'MONOTHERAPY'
named entity 'FOUND'
named entity 'CANCER'
named entity 'EFFECTS'
named entity 'NEED'
named entity 'THEIR'
named entity 'COMBINATION'
named entity 'LYSIS'
named entity 'BETTER'
covid:arg/afc99572834c677cd4f66c22e98eda2012f6f320
named entity 'immunotherapy'
named entity 'study'
named entity 'control'
named entity 'vaccinated'
named entity 'mice'
named entity 'TC-1'
named entity 'proteasome'
named entity 'specific'
named entity 'generate'
named entity 'lysis'
named entity 'HPV'
named entity 'CRT'
named entity 'CD8+'
named entity 'antitumor'
named entity 'antitumor'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software